Phase 3 Catalyst Focus: Social media chatter centers on the imminent REGAL Phase 3 overall survival readout for SELLAS Life Sciences' lead asset in acute myeloid leukemia. Participants note the stock's position as a higher-valuation dual-asset player ahead of this binary event.
Technical and Catalyst Outlook: Recent posts flag upcoming AACR data in late September and Q4 topline results for SLS009 as potential drivers. Analysts cited in discussions maintain buy ratings with targets spanning $25 to $35 amid observed oversold conditions.
Market Sentiment: Traders describe volatility around key support levels near $10.84 while anticipating rebounds on positive data releases. The overall tone reflects anticipation for clinical milestones in this high-risk biotech setting.
Note: This discussion summary was generated from an AI condensation of post data.
SELLAS Life Sciences Hedge Fund Activity
We have seen 133 institutional investors add shares of SELLAS Life Sciences stock to their portfolio, and 60 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- STATE STREET CORP added 4,600,202 shares (+54.8%) to their portfolio in Q2 2026, for an estimated $67,898,981
- ANSON FUNDS MANAGEMENT LP added 4,500,000 shares (+inf%) to their portfolio in Q2 2026, for an estimated $66,420,000
- BLACKROCK, INC. added 2,871,892 shares (+23.5%) to their portfolio in Q2 2026, for an estimated $42,389,125
- MARSHALL WACE, LLP removed 2,037,162 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $30,068,511
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 1,653,541 shares (+416.5%) to their portfolio in Q2 2026, for an estimated $24,406,265
- BNP PARIBAS FINANCIAL MARKETS added 1,025,006 shares (+2180.1%) to their portfolio in Q2 2026, for an estimated $15,129,088
- GEODE CAPITAL MANAGEMENT, LLC added 971,569 shares (+24.8%) to their portfolio in Q2 2026, for an estimated $14,340,358
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
